Whalesbook
Pfizer Limited's board of directors has recommended a final dividend of ₹75 per equity share for the financial year ending March 31, 2026. The company has set Friday, July 17, 2026, as the record date to determine which shareholders are eligible to receive this dividend. The recommendation was made during a board meeting on May 12, 2026.
This proposed dividend represents a return of value to shareholders, reflecting the company's financial performance. However, the ₹75 per share amount is notably lower than in previous years. For instance, Pfizer Limited declared a dividend of ₹170 per equity share for the financial year ended March 31, 2023.
While direct comparisons with peers like Dr. Reddy's (₹30 for FY24) and Sun Pharma (₹10 for FY24) can be complex due to different financial years and company-specific policies, Pfizer's proposed payout for FY26 signifies a reduction in its own dividend trend.
Shareholders who own Pfizer Ltd stock as of July 17, 2026, will be entitled to the recommended dividend. Investors will be watching for the company's official announcement of the exact dividend payment date, which is expected after final approvals. Future financial results and management commentary on dividend policy will also be closely monitored.